uk-mockup
PAGE 2 PAGE 3 • you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis
Download uk-mockup
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
Information, User, Leaflet, Packages, Package leaflet, Information for the user
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
Tapentadol (Palexia®) prolonged and immediate release ...
gmmmg.nhs.ukNovember 2015 Tapentadol (Palexia®) prolonged and immediate release tablets for the treatment of acute and chronic severe pain. The New Therapies Subgroup of the Greater Manchester Medicines
Release, Tablets, Immediate, Prolonged, Prolonged and immediate release tablets
AUSTRALIAN PRODUCT INFORMATION BETMIGA …
www.medicines.org.au1 australian product information – betmiga® (mirabegron) prolonged-release film-coated tablets 1 name of the medicine mirabegron 2 qualitative and quantitative composition
Release, Tablets, Coated, Film, Prolonged, Prolonged release film coated tablets
Lorvacs XL 1.5 mg Prolonged-release Tablets PL 27900 0001
www.mhra.gov.ukMHRA PAR; LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS, PL 27900/0001 2 LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS PL 27900/0001 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency (MHRA) granted a
Release, Tablets, Prolonged, Mg prolonged release tablets, Pl 27900, 27900, Mg prolonged release tablets pl 27900
Public Assessment Report Decentralised Procedure - GOV.UK
www.mhra.gov.ukPAR Mariosea, Dengaff and Trillblad XL 2 mg and 4 mg Prolonged-release Capsules UK/H/4976/001-2/DC UK/H/4977-8/001/DC 2 LAY SUMMARY Mariosea XL 2 mg Prolonged-release Capsules
Release, Capsule, Prolonged, Prolonged release capsules, Mariosea xl, Mariosea
Package leaflet: Information for the patient Ranexa 375 mg ...
www.medicines.org.uk1 Package leaflet: Information for the patient Ranexa 375 mg prolonged-release tablets Ranexa 500 mg prolonged-release tablets Ranexa 750 mg prolonged-release tablets